Ignite Institute

People in the News

Premium

Jeff Boyd, Dietrich Stephan, Gerry Higgins

The new institute will combine new equipment, namely 100 next-generation genome sequencers, with Fox Chase Cancer Center's resources, and the molecular biology experience and connections of Dietrich Stephan and his Institute for Individualized Health.

The two institutions will establish a new Cancer Genome Center at Fox Chase's Philadelphia campus, ending Ignite's year-long search for a permanent home.

The institute is evaluating technologies with an eye to joining vendors in co-creating the tools it will use toward translating personalized medicine discoveries, and remains intent on launching this year, President and CEO Dietrich Stephan said during a visit to GenomeWeb's offices.

The startup research center focused on personalized medicine is "currently evaluating a number of opportunities, both geographical and partnership-based," Dietrich Stephan, the institute's president and CEO, told GWDN.

The first 25 units will be installed and operational later this quarter when the institute moves into its permanent headquarters, the location of which is still being negotiated.

The institute hopes to attract "a multitude of other clinical partners that we're in discussions with, and have been for a while," President and CEO Dietrich Stephan told GenomeWeb Daily News.

The state's Subcommittee on Economic Development, Agriculture and Natural Resources approved $22 million in state funds for the new personalized medicine institute.

The Ignite Institute for Individualized Health, a new research institute in Northern Virginia, will receive 100 SOLiD 4 sequencers from Life Technologies this year, thus joining the ranks of other large US genome centers.

According to a company spokesperson, the firm has no other obligations to the institute under the collaboration besides supplying the sequencing instruments and related services.

Pages

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.